[HTML][HTML] Unravelling the genetic links between Parkinson's disease and lung cancer
Increase evidence from epidemiological studies have shown an inverse association
between Parkinson's disease (PD) and lung cancer. PD and lung cancer are both geriatric …
between Parkinson's disease (PD) and lung cancer. PD and lung cancer are both geriatric …
[HTML][HTML] Recent trends of lung cancer in Korea
JG Lee, HC Kim, CM Choi - Tuberculosis and Respiratory Diseases, 2021 - ncbi.nlm.nih.gov
Lung cancer is one of the leading causes of cancer-related deaths in Korea. Although the
smoking rate has decreased over time, the prevalence of lung cancer still remains high. In …
smoking rate has decreased over time, the prevalence of lung cancer still remains high. In …
High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with Targeted Therapy
BW Yoon, B Chang, SH Lee - OncoTargets and therapy, 2020 - Taylor & Francis
Purpose Although programmed death-ligand 1 (PD-L1) expression is widely accepted as a
predictive and prognostic biomarker in immunotherapy, its implications in lung cancer …
predictive and prognostic biomarker in immunotherapy, its implications in lung cancer …
NEIL3 mediates lung cancer progression and modulates PI3K/AKT/mTOR signaling: a potential therapeutic target
H Huang, Q Hua - International Journal of Genomics, 2022 - Wiley Online Library
Background. Nei endonuclease VIII‐like 3 (NEIL3) is widely involved in pathophysiological
processes of the body; however, its role in lung cancer has not been conclusively …
processes of the body; however, its role in lung cancer has not been conclusively …
[HTML][HTML] Characteristics of the immune cell infiltration landscape in gastric cancer to assistant immunotherapy
C Li, J Pan, Y Jiang, Y Yu, Z Jin, X Chen - Frontiers in genetics, 2022 - frontiersin.org
Background: Gastric cancer (GC) was usually associated with poor prognosis and invalid
therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to …
therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to …
Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer
M Yotsukura, K Nakagawa, K Suzuki… - Japanese Journal of …, 2021 - academic.oup.com
The superior efficacy of immune checkpoint inhibitors for the treatment of advanced non-
small cell lung cancer has inspired many clinical trials to use immune checkpoint inhibitors …
small cell lung cancer has inspired many clinical trials to use immune checkpoint inhibitors …
[HTML][HTML] New targeted therapy for non-small cell lung cancer
EK Chung, SH Yong, EH Lee, EY Kim… - Tuberculosis and …, 2023 - ncbi.nlm.nih.gov
Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men.
More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant …
More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant …
Diagnostic and Predictive Values of 18F-FDG PET/CT Metabolic Parameters in EGFR-Mutated Advanced Lung Adenocarcinoma
IK Hong, JM Lee, IK Hwang, SS Paik… - Cancer management …, 2020 - Taylor & Francis
Purpose The clinical implications of the metabolic parameters of 18F-fluorodeoxyglucose
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …
positron emission tomography-computed tomography (18F-FDG PET/CT) in epidermal …
[HTML][HTML] Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
C Li, J Pan, J Luo, X Chen - BMC Pulmonary Medicine, 2021 - Springer
Background Non-small cell lung cancer (NSCLC) was usually associated with poor
prognosis and invalid therapeutical response to immunotherapy due to biological …
prognosis and invalid therapeutical response to immunotherapy due to biological …
[HTML][HTML] A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma
Y Guo, G Li, M Xu, B Peng - Computers in Biology and Medicine, 2022 - Elsevier
Accumulating evidence suggests that long noncoding RNAs (lncRNAs) play a critical role in
regulating cancer immunity and the tumor microenvironment. Tumor-infiltrating …
regulating cancer immunity and the tumor microenvironment. Tumor-infiltrating …